# A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients.

> **NCT01736761** · PHASE4 · COMPLETED · sponsor: **St Stephens Aids Trust** · enrollment: 36 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Darunavir, Ritonavir and Rilpivirine

## Key facts

- **NCT ID:** NCT01736761
- **Lead sponsor:** St Stephens Aids Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01736761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01736761, "A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01736761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*